Orange Book product · Generic (ANDA)
MIFEPRISTONE
MIFEPRISTONE
Generic (ANDA)ANDA 211436TE ABRX TEVA PHARMS USA INC
At a glance
Aug 03, 2020
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 03, 2020
6 yr ago
Today
Pharmaceutical detail
Active ingredient
MIFEPRISTONE
Strength
300MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 211436
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of MIFEPRISTONE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
